PU11.02 Maraviroc less sensitive HIV-1 variants in a region where multiple non-B subtypes co-circulatePublication OnlyEpidemiology of HIV
PU11.01 Association between HIV infection and Diabetes Mellitus: a systematic review and meta-analysisPublication OnlyEpidemiology of HIV
PU09.02 'PrEP makes HIV irrelevant': The effect of PrEP on reducing HIV stigmaPublication OnlyDemand creation, market research, human-centred design
PU09.01 'If I knew about that, I wouldn't have stopped': increasing flexibility in PrEP use as a key to getting and keeping men on PrEPPublication OnlyDemand creation, market research, human-centred design
PU08.03 New in vitro release test methods for the dapivirine vaginal ringPublication OnlyDelivery technologies: novel approaches, formulation and multi-purpose
PU08.02 Low prevalence of likely depression among PrEP users in KenyaPublication OnlyDelivery technologies: novel approaches, formulation and multi-purpose
PU08.01 HIV status neutral community delivery of HIV pre-exposure prophylaxis to young men and women in rural KwaZulu-Natal: a pilotPublication OnlyDelivery technologies: novel approaches, formulation and multi-purpose
PU07.03 Epidemiological, clinical and immunological profile in SARS-CoV-2 co-infected HIV-positive young individualsPublication OnlyCOVID research: Applying lessons from HIV prevention to SARS CoV-2
PU07.02 It's not the time to be selfish: applying lessons learned from the HIV epidemic to COVID-19Publication OnlyCOVID research: Applying lessons from HIV prevention to SARS CoV-2
PU07.01 Learning from HIV prevention research: how hydroxychloroquine modifies the immune response and what could be the implications for prophylactic treatment of COVID-19Publication OnlyCOVID research: Applying lessons from HIV prevention to SARS CoV-2
seek-warrow-warrow-eseek-e41 - 50 of 444 items